Regulatory & Compliance

As AI-generated outputs like safety narrative summaries become part of the official evidentiary record, they face unprecedented scrutiny from global regulatory bodies during the drug approval process. The clinical trial landscape is currently undergoing a massive transformation as generative

Security experts are tracking an alarming trend of cyberattacks targeting third-party vendors like Veradigm to compromise the broader healthcare infrastructure. As healthcare systems increasingly outsource critical functions ranging from electronic health records management to predictive analytics,

While medication abortion is FDA-approved for use up to eleven weeks of pregnancy, a new legal effort argues that state-level bans are being undermined by mail-order access. This challenge, currently centered in Louisiana, targets the regulatory framework that allows physicians to prescribe

Bypassing traditional bureaucratic bodies like the World Health Organization may allow for more agile and direct coordination between the U.S. and China on biosecurity. As we navigate the complex landscape of 2026, the intersection of advanced large language models and synthetic biology has

In the United States, 300,000 new cases of breast cancer are diagnosed annually, many of which will eventually progress to a more resistant metastatic state. For patients facing these advanced stages, the traditional arsenal of chemotherapy and hormonal blockers often loses its efficacy over time,

Modern pharmaceutical development frequently stalls when chemists deliver a bulk powder that formulation scientists cannot effectively process into a stable dosage form. This persistent challenge is largely a relic of outdated, siloed organizational structures where drug substance synthesis and